{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:15:31Z","timestamp":1777655731263,"version":"3.51.4"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 AR071473"],"award-info":[{"award-number":["K23 AR071473"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24 AR080217"],"award-info":[{"award-number":["K24 AR080217"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rheumatology Research Foundatio","award":["892808"],"award-info":[{"award-number":["892808"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 1K23AI180356"],"award-info":[{"award-number":["K23 1K23AI180356"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029250","name":"Donald B. and Dorothy L. Stabler Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-AR070254"],"award-info":[{"award-number":["P30-AR070254"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rheumatic Diseases Research Core Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Anti-cytolethal distending toxin (CDT) antibodies may serve as biomarkers for post-infectious autoimmunity and aid clinical risk stratification. We aimed to determine the prevalence of anti-CDT antibodies in a large, well-characterized cohort of systemic sclerosis (SSc) patients and examine associations with gastrointestinal (GI) and extraintestinal clinical features and SSc-related antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sera from 130 SSc patients enriched for GI disease were screened for anti-CDT antibodies by ELISA. Clinical features, UCLA GIT 2.0-assessed symptoms and autoantibody profiles were compared between patients with and without anti-CDT antibodies. Linear mixed-effects models evaluated whether anti-CDT titres changed over time and correlated with longitudinal UCLA GIT 2.0 scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Anti-CDT antibodies were detected in 18% (23\/130) of SSc patients. Patients with anti-CDT antibodies more frequently had significant GI disease (87% vs 71%; P\u2009=\u20090.19) and were significantly more likely to have antibodies to U11\/U12 (RNPC3) (35% vs 4%; P\u2009&amp;lt;\u20090.001), U1RNP (26% vs 8%; P\u2009=\u20090.018) and topoisomerase-1 (30% vs 12%; P\u2009=\u20090.044). UCLA GIT Soilage scores were significantly higher among anti-CDT positive patients [median (interquartile range) 1 (1\u20132) vs 0 (0\u20132); P\u2009=\u20090.037]. In multivariable analyses, anti-CDT antibodies remained significantly associated with anti-U11\/U12 (RNPC3) [odds ratio (OR) 19.0 (95% CI: 4.3, 83.4); P\u2009\u2264\u20090.001], anti-U1RNP antibodies [OR 7.2 (95% CI: 1.9, 27.9); P\u2009=\u20090.004] and anti-topoisomerase-1 antibodies [OR 4.7 (95% CI: 1.3, 16.8); P\u2009=\u20090.019], even after adjusting for confounders. Anti-CDT titres did not change significantly over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Anti-CDT antibodies may serve as markers of post-infectious autoimmunity and strongly associate with SSc-autoantibodies linked to severe, progressive GI disease. Understanding the connection between anti-CDT antibodies and SSc-specific autoimmunity may provide insight into disease pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf376","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:27:39Z","timestamp":1752157659000},"page":"6349-6353","source":"Crossref","is-referenced-by-count":2,"title":["Anti-cytolethal distending toxin antibodies in systemic sclerosis: associations with gastrointestinal disease and immune dysregulation"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2491-7028","authenticated-orcid":false,"given":"Francesca Romana","family":"Di Ciommo","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, La Sapienza University of Rome , Rome,","place":["Italy"]},{"name":"Division of Rheumatology, UTHealth Houston , Houston, TX,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Casciola-Rosen","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2581-7992","authenticated-orcid":false,"given":"Ali Yagiz","family":"Ayla","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, UTHealth Houston , Houston, TX,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Balar","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, UTHealth Houston , Houston, TX,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami A","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3361-4909","authenticated-orcid":false,"given":"Michael","family":"Hughes","sequence":"additional","affiliation":[{"name":"Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Center for Musculoskeletal Research, The University of Manchester , Manchester,","place":["UK"]},{"name":"Department of Rheumatology, Northern Care Alliance NHS Foundation Trust, Salford Care Organisation , Salford,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Morales","sequence":"additional","affiliation":[{"name":"Karsh Division of Gastroenterology and MAST Program, Cedars-Sinai Medical Center , Los Angeles, CA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Pimentel","sequence":"additional","affiliation":[{"name":"Karsh Division of Gastroenterology and MAST Program, Cedars-Sinai Medical Center , Los Angeles, CA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-2435","authenticated-orcid":false,"given":"Brittany L","family":"Adler","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Johns Hopkins University School of Medicine , Baltimore, MD,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-8940","authenticated-orcid":false,"given":"Zsuzanna H","family":"McMahan","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, UTHealth Houston , Houston, TX,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"2025120216022786000_keaf376-B1","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1053\/j.gastro.2012.07.109","article-title":"Effects of scleroderma antibodies and pooled human immunoglobulin on anal sphincter and colonic smooth muscle function","volume":"143","author":"Singh","year":"2012","journal-title":"Gastroenterology"},{"key":"2025120216022786000_keaf376-B2","article-title":"Anti-mitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility","author":"McMahan","year":"2024","journal-title":"medRxiv"},{"key":"2025120216022786000_keaf376-B3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"key":"2025120216022786000_keaf376-B4","doi-asserted-by":"crossref","first-page":"369ra176","DOI":"10.1126\/scitranslmed.aaj1921","article-title":"Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis","volume":"8","author":"Konig","year":"2016","journal-title":"Sci Transl Med"},{"key":"2025120216022786000_keaf376-B5","doi-asserted-by":"crossref","first-page":"eabn5166","DOI":"10.1126\/scitranslmed.abn5166","article-title":"Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum","volume":"14","author":"Chriswell","year":"2022","journal-title":"Sci Transl Med"},{"key":"2025120216022786000_keaf376-B6","doi-asserted-by":"crossref","first-page":"e13875","DOI":"10.1111\/nmo.13875","article-title":"Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome","volume":"32","author":"Morales","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"2025120216022786000_keaf376-B7","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s10620-017-4585-z","article-title":"Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome","volume":"62","author":"Rezaie","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2025120216022786000_keaf376-B8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12016-010-8198-y","article-title":"Diagnosis and classification of systemic sclerosis","volume":"40","author":"Hachulla","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025120216022786000_keaf376-B9","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1007\/s10620-019-05684-6","article-title":"Second-generation biomarker testing for irritable bowel syndrome using plasma anti-CdtB and anti-vinculin levels","volume":"64","author":"Morales","year":"2019","journal-title":"Dig Dis Sci"},{"key":"2025120216022786000_keaf376-B10","doi-asserted-by":"crossref","first-page":"102727","DOI":"10.1016\/j.jaut.2021.102727","article-title":"Insights into the knowledge of complex diseases: environmental infectious\/toxic agents as potential etiopathogenetic factors of systemic sclerosis","volume":"124","author":"Ferri","year":"2021","journal-title":"J Autoimmun"},{"key":"2025120216022786000_keaf376-B11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/cells3020592","article-title":"The cytolethal distending toxin effects on Mammalian cells: a DNA damage perspective","volume":"3","author":"Bezine","year":"2014","journal-title":"Cells"},{"key":"2025120216022786000_keaf376-B12","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1128\/IAI.69.9.5752-5759.2001","article-title":"Cytolethal distending toxin demonstrates genotoxic activity in a yeast model","volume":"69","author":"Hassane","year":"2001","journal-title":"Infect Immun"},{"key":"2025120216022786000_keaf376-B13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00296-016-3437-z","article-title":"Anti-DNase I antibodies in systemic lupus erythematosus: diagnostic value and share in the enzyme inhibition","volume":"36","author":"Trofimenko","year":"2016","journal-title":"Rheumatol Int"},{"key":"2025120216022786000_keaf376-B14","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/acr.23763","article-title":"Anti-RNPC-3 (U11\/U12) antibodies in systemic sclerosis in patients with moderate-to-severe gastrointestinal dysmotility","volume":"71","author":"McMahan","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025120216022786000_keaf376-B15","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1093\/rheumatology\/keae469","article-title":"Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis","volume":"64","author":"Perin","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2025120216022786000_keaf376-B16","doi-asserted-by":"crossref","first-page":"e0126438","DOI":"10.1371\/journal.pone.0126438","article-title":"Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects","volume":"10","author":"Pimentel","year":"2015","journal-title":"PLoS One"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf376\/63723726\/keaf376.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/12\/6349\/63723726\/keaf376.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/12\/6349\/63723726\/keaf376.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T21:02:38Z","timestamp":1764709358000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/12\/6349\/8196171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,7,10]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf376","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,7,10]]}}}